Companies
TC BioPharma Announces Strategic Expansion with NK Cell Therapeutics
Acquisition of CAR-NK Assets to Bolster Cancer Therapy Portfolio TC BioPharm (TCBP), a leading biotechnology company specializing in allogeneic gamma-delta...
Candel Therapeutics Reports Encouraging Survival Data for CAN-2409 in Pancreatic Cancer
Updated Interim Results Show Prolonged Survival and Immune Activation in Borderline Resectable PDAC Patients Candel Therapeutics (CADL), a clinical-stage biopharmaceutical...
Tesla Explores India for $2-3 Billion Electric Car Plant
EV Giant Eyes Indian Market Amid Global Slowdown in Demand Tesla (TSLA) is gearing up to send a team to...
Coinbase Secures Registration in Canada, Expands Global Reach
Crypto Exchange Gains Foothold in Canadian Market Amid Regulatory Crackdowns Coinbase (COIN), a leading cryptocurrency exchange, has obtained registration in...
Ford Reports Robust Q1 Sales, Bolstered by Electrified Vehicles
Strong Performance in EVs and Hybrids Offset Decline in F-150 Sales Ford (F) has joined other legacy automakers in announcing...
JetBlue Pilots Seek New Labor Agreement
Air Line Pilots Association Calls for Negotiations on Pay and Working Conditions Nearly 5,000 pilots represented by the Air Line...
Fanapt Receives FDA Approval for Bipolar I Disorder Treatment
Vanda Pharmaceuticals Expands Fanapt Franchise with Novel Indication Vanda Pharmaceuticals (VNDA) has announced a significant milestone as the U.S. Food...
Amazon’s AWS Division Implements Layoffs Amidst Shifting Market Dynamics
Strategic Reorganization Follows Decelerating Sales Growth and Changes in Retail Landscape Amazon's (AMZN) cloud computing division, AWS, has announced significant...
Cathie Wood Forecasts Tesla at $2000; Eyes Reddit as Potential AI Venture
Ark Invest CEO's Projections Highlight Innovation in Tesla and Future Opportunities in AI-driven Platforms Ark Invest's Cathie Wood predicts Tesla's...
ARCA Biopharma and Oruka Therapeutics Announce Merger to Pave the Way for Advanced Biologic Treatments
Combined Entity Aims to Revolutionize Chronic Skin Disease Treatment with Cutting-Edge Antibodies ARCA biopharma (ABIO) and Oruka Therapeutics have finalized...
